Rapid Medical announced late-breaking results from the DISTALS trial evaluating the company’s Tigertriever 13 device for ...

Carotid revascularization did not lead to better cognitive performance compared with intensive medical therapy alone, according ...

Jupiter Endovascular, Inc. announced completion of patient enrollment in the SPIRARE II pivotal clinical trial evaluating the c ...

Sonorous Neurovascular announced that the FDA has granted Breakthrough Device designation for its BosSTENT, a braided, ...

Endospan, a privately held, Israel-based company focused on the endovascular repair of aortic arch disease, announced 1-year ...

Delivering intra-arterial alteplase after successful mechanical thrombectomy improved functional recovery in patients with larg ...

Phraxis Inc. announced the initiation of its postapproval study (PAS) for the EndoForce anastomotic connector. The company a ...

Gore & Associates announced European CE Mark approval of a 6- to 10-mm diameter range for the Gore Viatorr TIPS—trans ...

Imperative Care, Inc. announced the commercial launch and first patient cases of the new Zoom 4S catheter, an aspiration ...

Isabel Newton, MD, PhD, has been named Chief Medical Officer of Boston Scientific's Interventional Oncology and Embolizatio ...

AngioDynamics, Inc. and The PERT Consortium announced the launch of the ALPHA-PE Research Fund, an investigator-led initiative ...

Avantec Vascular, a Nipro company, announced FDA 510(k) clearance of its thrombectomy system, which is intended for the treatme ...